-
Published:
Drug pricing system
Committee:
Pharmaceuticalsstatus:
NewSince 2015, including the drastic reform of NHI price system in 2018, the predictability of the Japanese pharmaceuticals market and the attractiveness of the market have been significantly reduced and drug lags and drug losses have become apparent due to repeated revisions of the rules for calculating NHI prices, including the introduction of Off-year revisions and a review of the scope of the PMP. In 2022, an expert panel on comprehensive measures to realise a rapid and stable supply of pharmaceuticals was set up within the Ministry of Health, Labour and Welfare (MHLW) to make a comprehensive proposal.
-
Published:
Sustainability
Committee:
Logistics & Freightstatus:
NewThe logistics sector is active globally all over the world and plays a major role to reach a carbon neutral society. While there are some progress in Japan, the EBC believes that there is still plenty of improvements that can be made. We are at the same time fully aware that many of the policies are globally decided.
-
Published:
Overall sustainability governance
Committee:
Sustainability & Social Responsibilitystatus:
NewJapan under former Prime Minister Suga joined other countries in announcing that Japan will be carbon neutral by 2050. While the announcement was met with fanfare at the time, some of the momentum seems to have been lost. Not only where there no immediate follow-up, but concrete implementation has been slow.